ArticleBMC geriatrics2026
U-shaped association between hemoglobin levels and cardiometabolic multimorbidity in older adults: a large-scale cross-sectional study.
Article in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundMultimorbidity is common in older adults and associated with poor outcomes. Evidence for a nonlinear relationship between hemoglobin (Hb) levels and multimorbidity risk remains limited, particularly in large-scale studies. This study examines the dose-response relationship between Hb and cardiometabolic multimorbidity (CMM) to inform early risk assessment.
methodsThis cross-sectional study analyzed data from the National Primary Public Health Service System (NPPHSS) in Hainan Province, China, including 466,751 adults aged ≥ 65 years. Key variables included Hb levels, measured using the sodium lauryl sulfate method, and CMM (defined as the coexistence of ≥ 2 conditions among hypertension, diabetes, and hyperlipidemia). We used logistic regression and restricted cubic spline (RCS) models to assess the nonlinear dose-response relationship between Hb and CMM risk. Subgroup and sensitivity analyses were performed to assess the robustness of the findings.
resultsThe mean age was 74.6 ± 6.9 years; 56.4% were female. CMM prevalence was 32.1%. Mean Hb was 132.9 ± 15.4 g/L. RCS analysis revealed a significant nonlinear relationship (P for non-linear < 0.001). Odds ratios (ORs) formed a U-shaped curve, decreasing to a nadir at 112 g/L (OR = 0.885, 95% CI: 0.868 - 0.902) and rising with higher Hb levels, exceeding 1.0 above approximately 132 g/L. Subgroup analyses by sex, age, BMI, and multimorbidity patterns confirmed consistent U-shaped associations. Especially, among participants with all three chronic conditions, Hb ≥ 132 g/L or ≤ 83 g/L was positively associated with multimorbidity, and a negative association was noted in the Hb range of 104 - 132 g/L.
conclusionOur findings demonstrate a significant U-shaped association between Hb levels and CMM in Chinese older adults. Maintaining Hb within a reasonable range may be a consideration for primary prevention strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.